| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC5
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1
|
|
ABCF2
|
ATP-binding cassette, sub-family F (GCN20), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAD9
|
acyl-CoA dehydrogenase family, member 9
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTB
|
actin, beta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM33
|
ADAM metallopeptidase domain 33
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADSL
|
adenylosuccinate lyase
|
|
AFF3
|
AF4/FMR2 family, member 3
|
|
AFP
|
alpha-fetoprotein
|
|
AGRN
|
agrin
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AIRE
|
autoimmune regulator
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1
|
|
ALG11
|
ALG11, alpha-1,2-mannosyltransferase
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX12B
|
arachidonate 12-lipoxygenase, 12R type
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
|
AMH
|
anti-Mullerian hormone
|
|
AMN
|
amnion associated transmembrane protein
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G)
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle)
|
|
ANKRD55
|
ankyrin repeat domain 55
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANO3
|
anoctamin 3
|
|
ANO5
|
anoctamin 5
|
|
ANOS1
|
anosmin 1
|
|
ANTXR1
|
anthrax toxin receptor 1
|
|
ANXA2
|
annexin A2
|
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA5
|
apolipoprotein A-V
|
|
APOC2
|
apolipoprotein C-II
|
|
APOC3
|
apolipoprotein C-III
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGAP20
|
Rho GTPase activating protein 20
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARL11
|
ADP-ribosylation factor-like 11
|
|
ARMC5
|
armadillo repeat containing 5
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARX
|
aristaless related homeobox
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASIP
|
agouti signaling protein
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF1
|
activating transcription factor 1
|
|
ATF3
|
activating transcription factor 3
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AURKC
|
aurora kinase C
|
|
AXIN1
|
axin 1
|
|
AZF1
|
azoospermia factor 1
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BBS10
|
Bardet-Biedl syndrome 10
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCA3
|
breast cancer 3
|
|
BRD2
|
bromodomain containing 2
|
|
BSG
|
basigin (Ok blood group)
|
|
BTNL2
|
butyrophilin-like 2
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C11ORF95
|
chromosome 11 open reading frame 95
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
C2ORF71
|
chromosome 2 open reading frame 71
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CAPN3
|
calpain 3, (p94)
|
|
CARD14
|
caspase recruitment domain family, member 14
|
|
CARS
|
cysteinyl-tRNA synthetase
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV3
|
caveolin 3
|
|
CBFA2T2
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 2
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNH
|
cyclin H
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCT3
|
chaperonin containing TCP1, subunit 3 (gamma)
|
|
CCT6A
|
chaperonin containing TCP1, subunit 6A (zeta 1)
|
|
CD160
|
CD160 molecule
|
|
CD163
|
CD163 molecule
|
|
CD177
|
CD177 molecule
|
|
CD19
|
CD19 molecule
|
|
CD200
|
CD200 molecule
|
|
CD209
|
CD209 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD82
|
CD82 molecule
|
|
CD86
|
CD86 molecule
|
|
CD99
|
CD99 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH23
|
cadherin-related 23
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CENPH
|
centromere protein H
|
|
CEP63
|
centrosomal protein 63kDa
|
|
CERKL
|
ceramide kinase-like
|
|
CFH
|
complement factor H
|
|
CFHR3
|
complement factor H-related 3
|
|
CFI
|
complement factor I
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD2
|
chromodomain helicase DNA binding protein 2
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
|
|
CKM
|
creatine kinase, muscle
|
|
CLCN2
|
chloride channel, voltage-sensitive 2
|
|
CLDN1
|
claudin 1
|
|
CLDN2
|
claudin 2
|
|
CLDN4
|
claudin 4
|
|
CLDN7
|
claudin 7
|
|
CLECL1
|
C-type lectin-like 1
|
|
CLIC1
|
chloride intracellular channel 1
|
|
CLIP2
|
CAP-GLY domain containing linker protein 2
|
|
CLLU1
|
chronic lymphocytic leukemia up-regulated 1
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTFR
|
ciliary neurotrophic factor receptor
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
CNTNAP4
|
contactin associated protein-like 4
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COL6A1
|
collagen, type VI, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COL7A1
|
collagen, type VII, alpha 1
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COLQ
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
COPA
|
coatomer protein complex, subunit alpha
|
|
COQ2
|
coenzyme Q2 4-hydroxybenzoate polyprenyltransferase
|
|
COX7B
|
cytochrome c oxidase subunit VIIb
|
|
CPA6
|
carboxypeptidase A6
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPS1
|
carbamoyl-phosphate synthase 1, mitochondrial
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC3
|
CREB regulated transcription coactivator 3
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAG2
|
cancer/testis antigen 2
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTRC
|
chymotrypsin C (caldecrin)
|
|
CTSA
|
cathepsin A
|
|
CTSK
|
cathepsin K
|
|
CTTN
|
cortactin
|
|
CUL7
|
cullin 7
|
|
CUX1
|
cut-like homeobox 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A43
|
cytochrome P450, family 3, subfamily A, polypeptide 43
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DARS2
|
aspartyl-tRNA synthetase 2, mitochondrial
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCAF17
|
DDB1 and CUL4 associated factor 17
|
|
DCAF6
|
DDB1 and CUL4 associated factor 6
|
|
DCN
|
decorin
|
|
DCXR
|
dicarbonyl/L-xylulose reductase
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEFB1
|
defensin, beta 1
|
|
DES
|
desmin
|
|
DFNB31
|
deafness, autosomal recessive 31
|
|
DHH
|
desert hedgehog
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DMD
|
dystrophin
|
|
DNM2
|
dynamin 2
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DSP
|
desmoplakin
|
|
DTD1
|
D-tyrosyl-tRNA deacylase 1
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUOX2
|
dual oxidase 2
|
|
DYNLRB2
|
dynein, light chain, roadblock-type 2
|
|
DYSF
|
dysferlin
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDAR
|
ectodysplasin A receptor
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EFNB1
|
ephrin-B1
|
|
EFNB2
|
ephrin-B2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EHMT2
|
euchromatic histone-lysine N-methyltransferase 2
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF3E
|
eukaryotic translation initiation factor 3, subunit E
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELN
|
elastin
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
EMB
|
embigin
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EVC
|
Ellis van Creveld protein
|
|
EVC2
|
Ellis van Creveld syndrome 2
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXT1
|
exostosin glycosyltransferase 1
|
|
EXT2
|
exostosin glycosyltransferase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAM126A
|
family with sequence similarity 126, member A
|
|
FAM161A
|
family with sequence similarity 161, member A
|
|
FAM46C
|
family with sequence similarity 46, member C
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FAT1
|
FAT atypical cadherin 1
|
|
FBN1
|
fibrillin 1
|
|
FBXO31
|
F-box protein 31
|
|
FBXW4
|
F-box and WD repeat domain containing 4
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3
|
|
FCRL3
|
Fc receptor-like 3
|
|
FECH
|
ferrochelatase
|
|
FERMT1
|
fermitin family member 1
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FH
|
fumarate hydratase
|
|
FHIT
|
fragile histidine triad
|
|
FHL1
|
four and a half LIM domains 1
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FKRP
|
fukutin related protein
|
|
FKTN
|
fukutin
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXC1
|
forkhead box C1
|
|
FOXF1
|
forkhead box F1
|
|
FOXG1
|
forkhead box G1
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD4
|
frizzled class receptor 4
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GALNT3
|
polypeptide N-acetylgalactosaminyltransferase 3
|
|
GALT
|
galactose-1-phosphate uridylyltransferase
|
|
GAN
|
gigaxonin
|
|
GAS2L1
|
growth arrest-specific 2 like 1
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBA
|
glucosidase, beta, acid
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCGR
|
glucagon receptor
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF5
|
growth differentiation factor 5
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GFRA1
|
GDNF family receptor alpha 1
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GH1
|
growth hormone 1
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIF
|
gastric intrinsic factor (vitamin B synthesis)
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIS2
|
GLIS family zinc finger 2
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNE
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOSR2
|
golgi SNAP receptor complex member 2
|
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
|
GPC3
|
glypican 3
|
|
GPHN
|
gephyrin
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM6
|
glutamate receptor, metabotropic 6
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GUCY2D
|
guanylate cyclase 2D, membrane (retina-specific)
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HADHA
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBE1
|
hemoglobin, epsilon 1
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCN1
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HCN3
|
hyperpolarization activated cyclic nucleotide gated potassium channel 3
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCRTR2
|
hypocretin (orexin) receptor 2
|
|
HESX1
|
HESX homeobox 1
|
|
HFE
|
hemochromatosis
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMCN1
|
hemicentin 1
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOMEZ
|
homeobox and leucine zipper encoding
|
|
HOXA13
|
homeobox A13
|
|
HOXA9
|
homeobox A9
|
|
HOXB13
|
homeobox B13
|
|
HOXB3
|
homeobox B3
|
|
HOXD3
|
homeobox D3
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HR
|
hair growth associated
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH4
|
histamine receptor H4
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
HYLS1
|
hydrolethalus syndrome 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IFNK
|
interferon, kappa
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHMBP2
|
immunoglobulin mu binding protein 2
|
|
IGHV3-21
|
immunoglobulin heavy variable 3-21
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL23R
|
interleukin 23 receptor
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL36RN
|
interleukin 36 receptor antagonist
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ILDR1
|
immunoglobulin-like domain containing receptor 1
|
|
ILK
|
integrin-linked kinase
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
INF2
|
inverted formin, FH2 and WH2 domain containing
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRGM
|
immunity-related GTPase family, M
|
|
IRS4
|
insulin receptor substrate 4
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ISPD
|
isoprenoid synthase domain containing
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA8
|
integrin, alpha 8
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAG1
|
jagged 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JTB
|
jumping translocation breakpoint
|
|
JUNB
|
jun B proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNC2
|
potassium channel, voltage gated Shaw related subfamily C, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNV2
|
potassium channel, voltage gated modifier subfamily V, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0101
|
KIAA0101
|
|
KIAA1549
|
KIAA1549
|
|
KIF11
|
kinesin family member 11
|
|
KIF1A
|
kinesin family member 1A
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF1BP
|
KIF1 binding protein
|
|
KIF7
|
kinesin family member 7
|
|
KIFAP3
|
kinesin-associated protein 3
|
|
KIFC1
|
kinesin family member C1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT14
|
keratin 14, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
KRT6B
|
keratin 6B, type II
|
|
KRT7
|
keratin 7, type II
|
|
KRT75
|
keratin 75, type II
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LARP4
|
La ribonucleoprotein domain family, member 4
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LDHC
|
lactate dehydrogenase C
|
|
LDLR
|
low density lipoprotein receptor
|
|
LDOC1
|
leucine zipper, down-regulated in cancer 1
|
|
LEMD3
|
LEM domain containing 3
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIPC
|
lipase, hepatic
|
|
LMBR1
|
limb development membrane protein 1
|
|
LMNA
|
lamin A/C
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LOC643387
|
TAR DNA binding protein pseudogene
|
|
LOC646506
|
lysosomal-associated membrane protein 1 pseudogene
|
|
LOX
|
lysyl oxidase
|
|
LOXHD1
|
lipoxygenase homology domains 1
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRRFIP1
|
leucine rich repeat (in FLII) interacting protein 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2
|
|
MALT1
|
MALT1 paracaspase
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATN1
|
matrilin 1, cartilage matrix protein
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MFSD8
|
major facilitator superfamily domain containing 8
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR143
|
microRNA 143
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR155HG
|
MIR155 host gene
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR199A2
|
microRNA 199a-2
|
|
MIR199B
|
microRNA 199b
|
|
MIR21
|
microRNA 21
|
|
MIR219A2
|
microRNA 219a-2
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR223
|
microRNA 223
|
|
MIR335
|
microRNA 335
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKKS
|
McKusick-Kaufman syndrome
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MKS1
|
Meckel syndrome, type 1
|
|
MLANA
|
melan-A
|
|
MLF1
|
myeloid leukemia factor 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP21
|
matrix metallopeptidase 21
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MMS19
|
MMS19 nucleotide excision repair homolog (S. cerevisiae)
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MSMB
|
microseminoprotein, beta-
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSX1
|
msh homeobox 1
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MT-ND3
|
NADH dehydrogenase, subunit 3 (complex I)
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-TK
|
tRNA
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MTA1
|
metastasis associated 1
|
|
MTCP1
|
mature T-cell proliferation 1
|
|
MTFMT
|
mitochondrial methionyl-tRNA formyltransferase
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTMR14
|
myotubularin related protein 14
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MUTYH
|
mutY homolog
|
|
MVP
|
major vault protein
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH3
|
myosin, heavy chain 3, skeletal muscle, embryonic
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOT
|
myotilin
|
|
MYPN
|
myopalladin
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDE1
|
nudE neurodevelopment protein 1
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NEK6
|
NIMA-related kinase 6
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFIA
|
nuclear factor I/A
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NIPBL
|
Nipped-B homolog (Drosophila)
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX2-6
|
NK2 homeobox 6
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOG
|
noggin
|
|
NOL4L
|
nucleolar protein 4-like
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOTCH3
|
notch 3
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRXN3
|
neurexin 3
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTM
|
neurotrimin
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
OCLN
|
occludin
|
|
ODAM
|
odontogenic, ameloblast asssociated
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLFM4
|
olfactomedin 4
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
ONECUT1
|
one cut homeobox 1
|
|
ONECUT2
|
one cut homeobox 2
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OR51E1
|
olfactory receptor, family 51, subfamily E, member 1
|
|
OR51E2
|
olfactory receptor, family 51, subfamily E, member 2
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OTX1
|
orthodenticle homeobox 1
|
|
OTX2
|
orthodenticle homeobox 2
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P3H2
|
prolyl 3-hydroxylase 2
|
|
PAGR1
|
PAXIP1 associated glutamate-rich protein 1
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARL
|
presenilin associated, rhomboid-like
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX6
|
paired box 6
|
|
PAX7
|
paired box 7
|
|
PAX8
|
paired box 8
|
|
PBRM1
|
polybromo 1
|
|
PBX2
|
pre-B-cell leukemia homeobox 2
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHB
|
pyruvate dehydrogenase (lipoamide) beta
|
|
PDPN
|
podoplanin
|
|
PDYN
|
prodynorphin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PER3
|
period circadian clock 3
|
|
PEX1
|
peroxisomal biogenesis factor 1
|
|
PGAP3
|
post-GPI attachment to proteins 3
|
|
PGR
|
progesterone receptor
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
|
PHB
|
prohibitin
|
|
PHF6
|
PHD finger protein 6
|
|
PHKG2
|
phosphorylase kinase, gamma 2 (testis)
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIGL
|
phosphatidylinositol glycan anchor biosynthesis, class L
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive)
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKP1
|
plakophilin 1
|
|
PKP2
|
plakophilin 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAC1
|
placenta-specific 1
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCZ1
|
phospholipase C, zeta 1
|
|
PLEC
|
plectin
|
|
PLIN2
|
perilipin 2
|
|
PLXNA2
|
plexin A2
|
|
PML
|
promyelocytic leukemia
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLE2
|
polymerase (DNA directed), epsilon 2, accessory subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM16
|
PR domain containing 16
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROK1
|
prokineticin 1
|
|
PROK2
|
prokineticin 2
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRRX1
|
paired related homeobox 1
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTMA
|
prothymosin, alpha
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
PVALB
|
parvalbumin
|
|
PWAR5
|
Prader Willi/Angelman region RNA 5
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB18
|
RAB18, member RAS oncogene family
|
|
RAB3GAP1
|
RAB3 GTPase activating protein subunit 1 (catalytic)
|
|
RAB3GAP2
|
RAB3 GTPase activating protein subunit 2 (non-catalytic)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD51B
|
RAD51 paralog B
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAI1
|
retinoic acid induced 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RANBP2
|
RAN binding protein 2
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP7
|
retinoblastoma binding protein 7
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RDH12
|
retinol dehydrogenase 12 (all-trans/9-cis/11-cis)
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RLN1
|
relaxin 1
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNF135
|
ring finger protein 135
|
|
RNF213
|
ring finger protein 213
|
|
RNF8
|
ring finger protein 8, E3 ubiquitin protein ligase
|
|
RNU4ATAC
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RP1L1
|
retinitis pigmentosa 1-like 1
|
|
RPS26
|
ribosomal protein S26
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RTN3
|
reticulon 3
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
RYR3
|
ryanodine receptor 3
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SACS
|
sacsin molecular chaperone
|
|
SALL2
|
spalt-like transcription factor 2
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SATB1
|
SATB homeobox 1
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCARB2
|
scavenger receptor class B, member 2
|
|
SCLT1
|
sodium channel and clathrin linker 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCN1B
|
sodium channel, voltage gated, type I beta subunit
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC62
|
SEC62 homolog (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2
|
|
SEPT4
|
septin 4
|
|
SEPT9
|
septin 9
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETBP1
|
SET binding protein 1
|
|
SF3B4
|
splicing factor 3b, subunit 4, 49kDa
|
|
SFN
|
stratifin
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPC
|
surfactant protein C
|
|
SFTPD
|
surfactant protein D
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIL1
|
SIL1 nucleotide exchange factor
|
|
SIX3
|
SIX homeobox 3
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC19A3
|
solute carrier family 19 (thiamine transporter), member 3
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A13
|
solute carrier family 25 (aspartate/glutamate carrier), member 13
|
|
SLC25A15
|
solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 1
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC34A3
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 3
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A4
|
solute carrier family 7, member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLPI
|
secretory leukocyte peptidase inhibitor
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMC3
|
structural maintenance of chromosomes 3
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SNX10
|
sorting nexin 10
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX18
|
SRY (sex determining region Y)-box 18
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP110
|
SP110 nuclear body protein
|
|
SPAST
|
spastin
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SQLE
|
squalene epoxidase
|
|
SQSTM1
|
sequestosome 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRSF2
|
serine/arginine-rich splicing factor 2
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
SRY
|
sex determining region Y
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSTR2
|
somatostatin receptor 2
|
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
|
STAG2
|
stromal antigen 2
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STX16
|
syntaxin 16
|
|
STXBP1
|
syntaxin binding protein 1
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SURF1
|
surfeit 1
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
|
SYNM
|
synemin, intermediate filament protein
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAGLN3
|
transgelin 3
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBC1D32
|
TBC1 domain family, member 32
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBP
|
TATA box binding protein
|
|
TBX1
|
T-box 1
|
|
TBX19
|
T-box 19
|
|
TBX21
|
T-box 21
|
|
TBX22
|
T-box 22
|
|
TBX6
|
T-box 6
|
|
TCF4
|
transcription factor 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TDRD7
|
tudor domain containing 7
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFF1
|
trefoil factor 1
|
|
TFR2
|
transferrin receptor 2
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
TH
|
tyrosine hydroxylase
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THBS2
|
thrombospondin 2
|
|
THBS4
|
thrombospondin 4
|
|
THRB
|
thyroid hormone receptor, beta
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIMELESS
|
timeless circadian clock
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TKT
|
transketolase
|
|
TKTL1
|
transketolase-like 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TMEM216
|
transmembrane protein 216
|
|
TMEM67
|
transmembrane protein 67
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNNC1
|
troponin C type 1 (slow)
|
|
TNNI1
|
troponin I type 1 (skeletal, slow)
|
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPD52
|
tumor protein D52
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TPO
|
thyroid peroxidase
|
|
TRA
|
T cell receptor alpha locus
|
|
TRB
|
T cell receptor beta locus
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIAP1
|
TP53 regulated inhibitor of apoptosis 1
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSEN54
|
TSEN54 tRNA splicing endonuclease subunit
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTC21B
|
tetratricopeptide repeat domain 21B
|
|
TTC7A
|
tetratricopeptide repeat domain 7A
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTN
|
titin
|
|
TTPA
|
tocopherol (alpha) transfer protein
|
|
TTR
|
transthyretin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TUFT1
|
tuftelin 1
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBB
|
ubiquitin B
|
|
UBE2N
|
ubiquitin-conjugating enzyme E2N
|
|
UBE2Q2
|
ubiquitin-conjugating enzyme E2Q family member 2
|
|
UBE2V2
|
ubiquitin-conjugating enzyme E2 variant 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UMOD
|
uromodulin
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
UPF3B
|
UPF3 regulator of nonsense transcripts homolog B (yeast)
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIL1
|
villin 1
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VPS35
|
vacuolar protein sorting 35 homolog (S. cerevisiae)
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF2
|
WAS protein family, member 2
|
|
WDR36
|
WD repeat domain 36
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WISP3
|
WNT1 inducible signaling pathway protein 3
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT8B
|
wingless-type MMTV integration site family, member 8B
|
|
WT1
|
Wilms tumor 1
|
|
XCE
|
X chromosome controlling element
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZFHX3
|
zinc finger homeobox 3
|
|
ZFP57
|
ZFP57 zinc finger protein
|
|
ZIC1
|
Zic family member 1
|
|
ZIC2
|
Zic family member 2
|
|
ZIC3
|
Zic family member 3
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF384
|
zinc finger protein 384
|
|
ZNF630
|
zinc finger protein 630
|
|
ZNF699
|
zinc finger protein 699
|
|
ZNF804A
|
zinc finger protein 804A
|
